<qa>  What is the purpose of this study?The purpose of this study is to determine whether weekly paclitaxel followed by weekly doxorubicin plus daily oral cyclophosphamide without granulocyte colony-stimulating factor G-CSF is feasible in the treatment of locally advanced HER2-negative breast cancer. 